The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

If you're struggling with chronic low back pain, then this is for you. Brad: So we're going to show you three different ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...